延长释放药物疗法用于监禁人口中物质使用障碍:系统性审查
Amelia Woods1,2, Catherine Foley3, Katherine M Conigrave3,4,5
1National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Randwick, Australia.
Addiction (Abingdon, England)
|January 31, 2025
概括
延长释放布伦诺芬在减少阿片类药物使用和改善刑事司法系统中治疗保留方面表现有前途. 对于这个人群,延长释放纳尔德的有效性仍然不清楚.
科学领域:
- 成 药物 药物 药物 药物
- 刑事司法 卫生 刑事司法 卫生
- 药物治疗 药物治疗
背景情况:
- 毒品使用 (SU) 在刑事司法系统 (CJS) 中很常见,但治疗的机会有限.
- 评估监禁人员有效的药物疗法至关重要.
研究的目的:
- 评估延长释放纳尔德 (XR-NTX) 和延长释放布伦诺芬 (XR-BUP) 对CJS患者的疗效.
- 在监狱环境中综合这些药物治疗物质使用障碍的证据.
主要方法:
- 在多个数据库 (Scopus,PubMed,Embase等) 中进行系统的文献搜索. 从2002年至2022年期间.
- 包括对患有SU疾病的成年人 (18+) 的研究,XR治疗和最近的监禁.
- 使用RoB-2,ROBINS-I,JBI,以及Evers等人进行偏差风险评估. 工具. 工具. 这些工具.
主要成果:
- 分析了16项研究 (25篇论文),涉及3403名参与者.
- 在大多数阿片类药物使用研究中,XR-NTX显示了保留和SU的混合结果,在大多数阿片类药物使用研究中没有明显的优势.
- XR-BUP与语言下布伦诺芬相比,改善或相当于保留,具有混合的SU结果;没有观察到过量剂量的差异.
结论:
- 目前的证据并不清楚地支持XR-NTX或XR-BUP在CJS患者群体中的短效配方.
- 越来越多的证据表明,XR-BUP可以有效地减少阿片类药物使用,并提高该群体的治疗保留率.
- 尽管初始的药物开支,XR-BUP可能会提供成本优势.
相关概念视频
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications


